文献速递环境卫生妇幼与学校卫生卫生政策与健康促进

美国儿童血铅参考值更新至3.5 μg/dL(2021)

Update of the Blood Lead Reference Value - United States, 2021.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2021-10-29

美国CDC基于2015-2016和2017-2018周期NHANES数据,将儿童血铅参考值(BLRV)从5 μg/dL更新为3.5 μg/dL,取1-5岁儿童血铅分布第97.5百分位。该值用于指导个体儿童医学或环境随访,并帮助社区优先开展一级预防和评估预防效果。CDC建议筛查聚焦高风险人群,无本地筛查计划时推荐普遍血铅检测。

要点

  • 儿童BLRV更新为3.5 μg/dL,基于NHANES 2015-2018数据第97.5百分位。
  • BLRV用于判断个体儿童是否需医学或环境随访,并指导社区一级预防。
  • 无本地筛查计划时推荐普遍血铅检测, Medicaid儿童按CMS要求筛查。

核心结论

  • CDC将儿童血铅参考值更新为3.5 μg/dL,以识别血铅高于美国多数儿童者并推进健康公平。

研究设计与样本

  • 基于美国国家健康与营养调查(NHANES)2015-2016和2017-2018周期数据,取1-5岁儿童血铅分布第97.5百分位。

主要发现

  • 科学证据表明不存在已知的安全血铅水平,即使少量铅也可损害儿童发育中的大脑。
  • 初始BLRV为5 μg/dL(2012年建立),基于2007-2008和2009-2010 NHANES周期数据。

关键数值与推荐

  • 儿童BLRV更新为3.5 μg/dL,对应1-5岁儿童血铅分布第97.5百分位(NHANES 2015-2018)。
  • CDC建议筛查聚焦基于住房年龄和社会人口学风险因素的高风险人群。
  • 无本地筛查计划时推荐普遍血铅检测。
  • 遵循CMS要求,所有参保Medicaid儿童在12和24月龄检测,或24-72月龄未筛查者补测。

临床怎么用

  • 公共卫生和临床专业人员应合作制定响应本地条件的筛查计划。
  • BLRV作为指南帮助判断个体儿童是否启动医学或环境随访行动。
  • 利用BLRV优先社区一级预防并评估预防效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The negative impact of lead exposure on young children and those who become pregnant is well documented but is not well known by those at highest risk from this hazard. Scientific evidence suggests that there is no known safe blood lead level (BLL), because even small amounts of lead can be harmful to a child's developing brain (1). In 2012, CDC introduced the population-based blood lead reference value (BLRV) to identify children exposed to more lead than most other children in the United States. The BLRV should be used as a guide to 1) help determine whether medical or environmental follow-up actions should be initiated for an individual child and 2) prioritize communities with the most need for primary prevention of exposure and evaluate the effectiveness of prevention efforts. The BLRV is based on the 97.5th percentile of the blood lead distribution in U.S. children aged 1-5 years from National Health and Nutrition Examination Survey (NHANES) data. NHANES is a complex, multistage survey designed to provide a nationally representative assessment of health and nutritional status of the noninstitutionalized civilian adult and child populations in the United States (2). The initial BLRV of 5 μg/dL, established in 2012, was based on data from the 2007-2008 and 2009-2010 NHANES cycles. Consistent with recommendations from a former advisory committee, this report updates CDC's BLRV in children to 3.5 μg/dL using NHANES data derived from the 2015-2016 and 2017-2018 cycles and provides helpful information to support adoption by state and local health departments, health care providers (HCPs), clinical laboratories, and others and serves as an opportunity to advance health equity and environmental justice related to preventable lead exposure. CDC recommends that public health and clinical professionals focus screening efforts on populations at high risk based on age of housing and sociodemographic risk factors. Public health and clinical professionals should collaborate to develop screening plans responsive to local conditions using local data. In the absence of such plans, universal BLL testing is recommended. In addition, jurisdictions should follow the Centers for Medicare & Medicaid Services requirement that all Medicaid-enrolled children be tested at ages 12 and 24 months or at age 24-72 months if they have not previously been screened (3).

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Ruckart PZ, Jones RL, Courtney JG, et al. Update of the Blood Lead Reference Value - United States, 2021. MMWR Morb Mortal Wkly Rep. 2021. PMID: 34710078. doi:10.15585/mmwr.mm7043a4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。